Sagimet Biosciences Inc. (SGMT) Total liabilities

Sagimet Biosciences Inc. (SGMT) total liabilities at each fiscal year-end, per SEC filings.

$5.7MFY2024

Fiscal year	Value	YoY
FY2024	$5.7M	—

Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.

Source: SEC XBRL filings · For reference only · Not investment advice

More SGMT financial trends

SGMT Revenue SGMT Net income SGMT Net margin SGMT Gross profit SGMT Gross margin SGMT Operating income SGMT Operating margin SGMT Operating cash flow SGMT Free cash flow SGMT Capital expenditures SGMT Return on equity SGMT Stock buybacks SGMT Dividends paid SGMT Total assets SGMT Shareholders’ equity SGMT overview →